Cencora Inc.
COR | NYSE
$308.78
-$0.63 (-0.20%)
At close: Sep 18, 2026, 4:00 PM ET
$307.01
-$1.77 (-0.57%)
Pre-market:
Sep 21, 2026, 7:17 AM ET
Company Profile
Cencora, Inc. functions as a global leader in the sourcing and distribution of pharmaceutical products, with operations spanning both the United States and international markets. Within its U.S. Healthcare Solutions segment, the company supplies a broad spectrum of pharmaceutical items, including generic and injectable medications, over-the-counter health products, and home healthcare equipment. Its extensive client network includes acute care hospitals, health systems, a variety of retail and mail-order pharmacies (independent, chain, long-term care), medical clinics, and other healthcare providers. This division also manages the distribution of crucial specialized pharmaceutical products like plasma, blood derivatives, and vaccines. Beyond product supply, Cencora offers comprehensive support services, such as pharmacy management, staffing solutions, and strategic consulting. It develops and implements supply management software, provides packaging services for both institutional and retail healthcare settings, and assists with clinical trial support, post-market approval processes, and commercialization strategies. For biotechnology and pharmaceutical manufacturers, the company delivers data analytics, outcomes research, and other specialized services. Furthermore, Cencora serves the animal health market, providing pharmaceuticals, vaccines, parasiticides, diagnostics, and micro feed ingredients for both companion and production animals. It also offers sales force support to manufacturers and specialized services to medical professionals, particularly oncologists, as well as to hospitals and dialysis clinics. The International Healthcare Solutions division concentrates on global pharmaceutical wholesale activities, associated services, and worldwide commercialization support. It ensures the efficient distribution of medicines, various healthcare goods, and related services to an international customer base comprising pharmacies, doctors, health centers, and hospitals. This segment also delivers specialized transportation and logistics solutions specifically designed for the biopharmaceutical sector. Founded in 1871, the company was formerly known as AmerisourceBergen Corporation before adopting the name Cencora, Inc. in August 2023. Its corporate headquarters are situated in Conshohocken, Pennsylvania.
Key Executives
| Name | Position |
|---|---|
| Robert Mauch | President, Chief Executive Officer & Director |
| Elizabeth S. Campbell | Executive Vice President & Chief Legal Officer |
| Eva C. Boratto | Executive Vice President & Chief Financial Officer |
| Bennett S. Murphy | Senior VP Of Investor Relations & Enterprise Productivity and Treasury |
| François Mandeville | Executive Vice President and Chief Strategy and M&A Officer |
| James F. Cleary Jr. | Advisor |
| Juan Guerra | EVP & President of International Business Group |
| Lazarus Krikorian | Senior Vice President, Chief Accounting Officer & Corporate Controller |
| Pawan Singh Verma | Executive Vice President and Chief Data & Information Officer |
| Richard Tremonte | EVP and President of U.S. Pharmaceuticals & Animal Health |
| Samantha L. Hammock | Executive Vice President & Chief Human Resources Officer |
| Silvana Battaglia | Advisor |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Sep 02, 2026 | 4 | Filing |
| Aug 25, 2026 | 4 | Filing |
| Aug 14, 2026 | 8-K | Current Report |
| Aug 12, 2026 | 8-K | Current Report |
| Aug 05, 2026 | 10-Q | Quarterly Report |
| Aug 05, 2026 | 8-K | Current Report |
| Aug 05, 2026 | 8-K | Current Report |
| Aug 04, 2026 | 4 | Filing |
| Aug 04, 2026 | 4 | Filing |
| Aug 04, 2026 | 4 | Filing |
Cencora Inc.
| Country | United States |
| IPO Date | Apr 3, 1995 |
| Industry | Medical - Distribution |
| Sector | Healthcare |
| Employees | 49,000 |
| CEO | Robert Mauch |
Contact Details
1 West First Avenue Conshohocken,
Pennsylvania 19428-1800 United States
Stock Details
| Ticker Symbol | COR |
| Exchange | NYSE |
| Fiscal Year | October - September |
| Reporting Currency | USD |
| CIK Code | 0001140859 |
| CUSIP Number | 03073E105 |
| ISIN Number | US03073E1055 |
| SIC Code | 5122 |
Recent News
- 6 hours ago / marketbeat.comCencora Highlights Specialty Growth, MSO Expansion and Walgreens Ties at Conference
- 3 days ago / zacks.comHere's Why Cencora (COR) is a Strong Value Stock
- 5 days ago / seekingalpha.comCencora, Inc. (COR) Presents at 2026 Global Healthcare Conference Transcript
- 6 days ago / seekingalpha.comCencora, Inc. (COR) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
- 11 days ago / zacks.comHere's Why Cencora (COR) is a Strong Momentum Stock
- 13 days ago / seekingalpha.comCencora, Inc. (COR) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript
- 14 days ago / zacks.comWhy Cencora (COR) is a Top Growth Stock for the Long-Term
- 17 days ago / zacks.comHere's Why You Should Retain Cencora Stock in Your Portfolio for Now
- 17 days ago / zacks.comCencora (COR) Up 3.8% Since Last Earnings Report: Can It Continue?
- 17 days ago / zacks.comCencora Launches Cell and Gene Therapy Enablement for Health Systems
Add to Watchlist
Select watchlists to add or remove COR